"10.1371_journal.pone.0018526","plos one","2011-04-13T00:00:00Z","Samuel O Pine; James G Kublin; Scott M Hammer; Joleen Borgerding; Yunda Huang; Danilo R Casimiro; M Juliana McElrath","Program in Pathobiology, Department of Global Health, University of Washington, Seattle, Washington, United States of America; Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Division of Infectious Diseases, Columbia University College of Physicians and Surgeons, New York, New York, United States of America; Vaccine Basic Research, Merck Research Laboratories, West Point, Pennsylvania, United States of America","Conceived and designed the experiments: SOP MJM. Performed the experiments: SOP DRC. Analyzed the data: SOP JB YH. Contributed reagents/materials/analysis tools: JGK SMH DRC MJM. Wrote the paper: SOP JB MJM.","Danilo R. Casimiro is an employee of Merck Research Laboratories, which provided the vaccine product tested in the HVTN 050 clinical trial, from which the samples used in this research were obtained. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials. No other competing interests exist.","2011","04","Samuel O Pine","SOP",7,TRUE,2,2,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
